A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

NCT07749586 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

499

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: ARV-6723
DRUG: Pembrolizumab
DRUG: SOC

Sponsor

Arvinas Inc.